<p>Organigram Holdings Inc.（TSE:OGI - 获取免费报告）高管 Paolo De Luca 在周三，9 月 11 日进行交易中出售了公司股票的 13,835 股。股票以平均价格 2.54 加元出售，总价值为 35,140.90 加元。交易完成后，内部人士现在直接持有公司股票 625 股，价值约为 1,587.50 加元。</p>
<p>Paolo De Luca 最近还进行了以下交易：</p>
<ul>
<li>在 8 月 16 日星期五，Paolo De Luca 出售了 Organigram 股票的 10,266 股。股票以平均价格 2.76 加元出售，总价值为 28,334.16 加元。</li>
</ul>
<h2>Organigram 股票表现</h2>
<p>OGI 股票在周五的午盘交易中上涨了 0.04 加元，达到 2.53 加元。该股交易量为 258,414 股，相比平均交易量 319,274 股。该公司的 50 天简单移动平均线为 2.37 加元，200 天简单移动平均线为 2.51 加元。该股市值为 2.7468 亿加元，市盈率为-1.00，市盈增长比为 0.42，贝塔系数为 1.13。公司的资产负债比为 1.13，速动比率为 2.62，流动比率为 6.95。Organigram Holdings Inc.的 52 周最低价为 1.35 加元，52 周最高价为 3.95 加元。</p>
<p>Organigram（TSE:OGI - 获取免费报告）最近公布了其财报，日期为 8 月 13 日星期二。公司报告该季度每股收益为 0.03 加元，超过了每股-0.07 加元的共识预期 0.10 加元。Organigram 的净利润率为-153.80%，净资产收益率为-54.53%。该公司在该季度的营收为 4106 万加元，而分析师预期为 3920 万加元。作为一个团体，股票研究分析师预计 Organigram Holdings Inc.今年将发布 0.1735254 的每股收益。</p>
<h2>分析师评级变动</h2>
<p>OGI 最近成为几份分析师报告的主题。Jefferies Financial Group 在 5 月 17 日的一份报告中将 Organigram 的目标价从 4.40 加元降至 4.35 加元。Canaccord Genuity Group 将 Organigram 的目标价从 3.25 加元上调至 3.60 加元，并在 8 月 14 日的研究报告中给予该股 “投机性买入” 评级。</p>
<p><strong>查看我们关于 Organigram 的最新研究报告</strong></p>
<h2>Organigram 公司简介（获取免费报告）</h2>
<p>Organigram Holdings Inc.及其子公司在加拿大从事大麻及大麻衍生产品的生产和销售。公司提供医用大麻产品，包括整花、研磨花、预卷烟、注入预卷烟、电子烟、软糖和浓缩物品，供医疗零售商销售；在 SHRED、Holy Mountain、Big Bag O' Buds、Monjour、Trailblazer、SHRED'ems、Edison Cannabis Co、Edison JOLTS、Tremblant 和 Laurentian 品牌下提供成人娱乐用大麻。</p>
<h2>精选故事</h2>
<ul>
<li>我们比 Organigram 更喜欢的五支股票</li>
<li>什么是支撑位？</li>
<li>为您的投资组合提供动力：公用事业部门的电力激增</li>
<li>便士股票是否适合您的投资组合？</li>
<li>Adobe 股票建立长期价值：考虑在低点买入</li>
<li>何时出售股票获利或止损</li>
<li>随着锂股购买狂潮的兴起，Albemarle 股价飙升</li>
</ul>
<p><em>这则即时新闻警报是由叙事科技和 MarketBeat 的财务数据生成，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<p>→ 在 9 月 18 日交易结束前投资（来自交易达人）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NTYw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NTYw"/></p>
<h2>您现在是否应该投资 1,000 加元购买 Organigram 股票？</h2>
<p>在考虑 Organigram 之前，您可能想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶尖和表现最佳的研究分析师以及他们向客户推荐的股票。MarketBeat 已确定了顶尖分析师悄悄告诉客户在更广泛市场注意之前现在购买的五支股票... Organigram 不在名单上。</p>
<p>尽管 Organigram 目前在分析师中有 “中等买入” 评级，但顶尖分析师认为这五支股票更值得购买。</p>
<p>查看这五支股票</p>

<p>保罗·德卢卡（Paolo De Luca）是 Organigram Holdings Inc.（TSE:OGI）的高级官员，于 9 月 11 日以平均价格为 C$0.54 出售了公司股票的 13,835 股，总价值为 C$7,440.90。售出后，他持有价值约为 C$587.50 的 625 股。此前，他于 8 月 16 日以 C$0.76 的价格出售了 10,266 股。Organigram 的股票表现显示市值为 C$68 百万，市盈率为-1.00，52 周价格范围为 C$0.35 至 C$0.95。分析师对该股票的评级褒贬不一，有些降低了目标价，而有些则提高了</p>

<p>Organigram Holdings Inc. (TSE:OGI - Get Free Report) Senior Officer Paolo De Luca sold 13,835 shares of the firm's stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of C$2.54, for a total value of C$35,140.90. Following the completion of the sale, the insider now directly owns 625 shares of the company's stock, valued at approximately C$1,587.50.</p>
<div class="lb-trans"><p>Organigram Holdings Inc.（TSE:OGI - 获取免费报告）高管 Paolo De Luca 在周三，9 月 11 日进行交易中出售了公司股票的 13,835 股。股票以平均价格 2.54 加元出售，总价值为 35,140.90 加元。交易完成后，内部人士现在直接持有公司股票 625 股，价值约为 1,587.50 加元。</p>
</div><p>Paolo De Luca also recently made the following trade(s):</p>
<ul>
<li>On Friday, August 16th, Paolo De Luca sold 10,266 shares of Organigram stock. The stock was sold at an average price of C$2.76, for a total value of C$28,334.16.</li>
</ul>
<div class="lb-trans"><p>Paolo De Luca 最近还进行了以下交易：</p>
<ul>
<li>在 8 月 16 日星期五，Paolo De Luca 出售了 Organigram 股票的 10,266 股。股票以平均价格 2.76 加元出售，总价值为 28,334.16 加元。</li>
</ul>
</div><h2>Organigram Stock Performance</h2>
<div class="lb-trans"><h2>Organigram 股票表现</h2>
</div><p>OGI stock traded up C$0.04 during midday trading on Friday, reaching C$2.53. The stock had a trading volume of 258,414 shares, compared to its average volume of 319,274. The firm has a fifty day simple moving average of C$2.37 and a two-hundred day simple moving average of C$2.51. The stock has a market cap of C$274.68 million, a PE ratio of -1.00, a P/E/G ratio of 0.42 and a beta of 1.13. The company has a debt-to-equity ratio of 1.13, a quick ratio of 2.62 and a current ratio of 6.95. Organigram Holdings Inc. has a 52-week low of C$1.35 and a 52-week high of C$3.95.</p>
<div class="lb-trans"><p>OGI 股票在周五的午盘交易中上涨了 0.04 加元，达到 2.53 加元。该股交易量为 258,414 股，相比平均交易量 319,274 股。该公司的 50 天简单移动平均线为 2.37 加元，200 天简单移动平均线为 2.51 加元。该股市值为 2.7468 亿加元，市盈率为-1.00，市盈增长比为 0.42，贝塔系数为 1.13。公司的资产负债比为 1.13，速动比率为 2.62，流动比率为 6.95。Organigram Holdings Inc.的 52 周最低价为 1.35 加元，52 周最高价为 3.95 加元。</p>
</div><p>Organigram (TSE:OGI - Get Free Report) last posted its earnings results on Tuesday, August 13th. The company reported C$0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of C($0.07) by C$0.10. Organigram had a negative net margin of 153.80% and a negative return on equity of 54.53%. The firm had revenue of C$41.06 million during the quarter, compared to analysts' expectations of C$39.20 million. As a group, equities research analysts anticipate that Organigram Holdings Inc. will post 0.1735254 EPS for the current year.</p>
<div class="lb-trans"><p>Organigram（TSE:OGI - 获取免费报告）最近公布了其财报，日期为 8 月 13 日星期二。公司报告该季度每股收益为 0.03 加元，超过了每股-0.07 加元的共识预期 0.10 加元。Organigram 的净利润率为-153.80%，净资产收益率为-54.53%。该公司在该季度的营收为 4106 万加元，而分析师预期为 3920 万加元。作为一个团体，股票研究分析师预计 Organigram Holdings Inc.今年将发布 0.1735254 的每股收益。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>OGI has been the subject of several recent analyst reports. Jefferies Financial Group lowered their price target on Organigram from C$4.40 to C$4.35 in a report on Friday, May 17th. Canaccord Genuity Group raised their target price on Organigram from C$3.25 to C$3.60 and gave the stock a &#34;speculative buy&#34; rating in a research note on Wednesday, August 14th.</p>
<div class="lb-trans"><p>OGI 最近成为几份分析师报告的主题。Jefferies Financial Group 在 5 月 17 日的一份报告中将 Organigram 的目标价从 4.40 加元降至 4.35 加元。Canaccord Genuity Group 将 Organigram 的目标价从 3.25 加元上调至 3.60 加元，并在 8 月 14 日的研究报告中给予该股 “投机性买入” 评级。</p>
</div><p><strong>Check Out Our Latest Research Report on Organigram</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Organigram 的最新研究报告</strong></p>
</div><h2>Organigram Company Profile (Get Free Report)</h2>
<div class="lb-trans"><h2>Organigram 公司简介（获取免费报告）</h2>
</div><p>Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.</p>
<div class="lb-trans"><p>Organigram Holdings Inc.及其子公司在加拿大从事大麻及大麻衍生产品的生产和销售。公司提供医用大麻产品，包括整花、研磨花、预卷烟、注入预卷烟、电子烟、软糖和浓缩物品，供医疗零售商销售；在 SHRED、Holy Mountain、Big Bag O' Buds、Monjour、Trailblazer、SHRED'ems、Edison Cannabis Co、Edison JOLTS、Tremblant 和 Laurentian 品牌下提供成人娱乐用大麻。</p>
</div><h2>Featured Stories</h2>
<ul>
<li>Five stocks we like better than Organigram</li>
<li>What is a support level?</li>
<li>Powering Your Portfolio: The Utility Sector's Electrifying Surge</li>
<li>Are Penny Stocks a Good Fit for Your Portfolio?</li>
<li>Adobe Stock Builds Long-Term Value: Consider Buying on the Dip</li>
<li>When to Sell a Stock for Profit or Loss</li>
<li>Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off</li>
</ul>
<div class="lb-trans"><h2>精选故事</h2>
<ul>
<li>我们比 Organigram 更喜欢的五支股票</li>
<li>什么是支撑位？</li>
<li>为您的投资组合提供动力：公用事业部门的电力激增</li>
<li>便士股票是否适合您的投资组合？</li>
<li>Adobe 股票建立长期价值：考虑在低点买入</li>
<li>何时出售股票获利或止损</li>
<li>随着锂股购买狂潮的兴起，Albemarle 股价飙升</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>这则即时新闻警报是由叙事科技和 MarketBeat 的财务数据生成，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><p>→ Invest before this deal closes on 9/18 (From Deal Maker)(Ad)</p>
<div class="lb-trans"><p>→ 在 9 月 18 日交易结束前投资（来自交易达人）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NTYw" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9560&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Organigram right now?</h2>
<div class="lb-trans"><h2>您现在是否应该投资 1,000 加元购买 Organigram 股票？</h2>
</div><p>Before you consider Organigram, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Organigram 之前，您可能想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶尖和表现最佳的研究分析师以及他们向客户推荐的股票。MarketBeat 已确定了顶尖分析师悄悄告诉客户在更广泛市场注意之前现在购买的五支股票... Organigram 不在名单上。</p>
</div><p>While Organigram currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Organigram 目前在分析师中有 “中等买入” 评级，但顶尖分析师认为这五支股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五支股票</p>
</div>

Paolo De Luca 出售了 13,835 股 Organigram Holdings Inc. (TSE:OGI) 的股票